Conflict of Interest
More Information on Conflict of Interest
- Congressional Testimony on State Laws Requiring Disclosure of Pharmaceutical Company Payments to Physicians, June 27, 2007
- Letter Regarding Prescription Drug User Fee Act, May 4, 2007
- Article in JAMA: Pharmaceutical Company Payments to Physicians, March 21, 2007
- Article in JAMA: Financial Conflict of Interest Disclosure at FDA Drug Advisory Committee Meetings, April 26, 2006
- Letter Questioning the Actions of a Senior NIH Scientist and Former AstraZeneca Consultant, July 8, 2004
- Letter Concerning Potential Conflict of Interest Between Silicone Implant Advisory Committee Member and Inamed Aesthetics, November 17, 2003
- Comments on the Disclosure of Conflicts of Interest for Participants in FDA Advisory Committees, March 5, 2002
- Comments on the Prescription Drug User Fee Act (PDUFA), January 25, 2002
- Letter on Drug Industry Influence on Medical Residents, April 26, 2001
- Comments on the Prescription Drug Marketing Act of 1987, October 27, 2000
- Testimony on Prescription Drug User Fee Act (PDUFA), September 15, 2000